Online Controlled Substances Summit
Virtual Meeting
Public Session: July 25, 2024 | 11am-2pm (eastern)
Closed Working Session: July 26, 2024 | 11am-4pm (eastern)
The sale of controlled substances over the internet poses significant health risks to consumers of all ages. Continued availability of controlled substances—such as opioids, benzodiazepines, and stimulants—through social media, websites, and other online platforms exacerbates public health concerns due to the heightened risks associated with the combined use of these products.
This fully virtual event, with two half-day sessions, will focus on identifying innovative solutions to reduce the availability of controlled substances online. Given the evolving online landscape for controlled substances, it is crucial that public and private stakeholders continue to develop effective strategies and innovative solutions that can combat this tremendous public health threat.
Join the Food and Drug Administration (FDA) and the Reagan-Udall Foundation for the FDA for the fifth Online Controlled Substances Summit.
See the Full Public Session Agenda
Public Session Agenda
11am |
WelcomeSusan C. Winckler, RPh, Esq., Reagan-Udall Foundation for the FDA |
---|---|
11:05am |
Introductory RemarksRobert M. Califf, MD, Commissioner of Food and Drugs, FDA |
11:20am |
Session 1: Perspectives from the FDAPresenters:
|
11:40am |
Session 2: Perspectives from the Real WorldPresenters:
|
12pm |
Session 3: Online Availability of Controlled Substances: A SnapshotPresenters:
Reactor Panelists:
|
1pm |
Session 4: Going Beyond the MessagePresenters:
|
1:15pm |
Session 5: Perspectives from the Tech SectorPanelists:
|
1:55pm |
Closing RemarksMarta Sokolowska, PhD, Deputy Center Director, Substance Use and Behavioral Health, Center for Drug Evaluation and Research, FDA |
2pm |
Adjourn |